Rybelsus 7 mg is an oral diabetes medication containing Semaglutide, a GLP-1 receptor agonist designed to control blood sugar in adults with type 2 diabetes. It’s a breakthrough drug because it delivers the same benefits as injectable GLP-1 medicines — but in